Market Research Report
Europe Protein Sequencing Market Forecast 2020-2028
|Published by||Inkwood Research||Product code||928600|
|Published||Content info||90 Pages
Delivery time: 2-3 business days
|Europe Protein Sequencing Market Forecast 2020-2028|
|Published: March 16, 2020||Content info: 90 Pages||
The Europe protein sequencing market is anticipated to register a CAGR of 6.29% over the estimated period of 2020-2028. The high growth potential of the European market owing to the ongoing developments in the next-generation sequencing techniques. Data analysis software, R&D and technological innovation of the sequencing platforms, application of cloud computing to stire data, and data storage and management are the factors fueling the market growth in the region.
The growth of the European market of protein sequencing is studied on the basis of the markets situated in the countries in the region such as Italy, Russia, Poland, Germany, Belgium, France, the UK, and the rest of Europe that includes Denmark, Netherlands, Spain, Sweden, and others. The Russian market is showcasing growth due to the improving biotech and healthcare industries. The state initiatives have given a strong drive to establish new manufacturing facilities in the country. The new factory opened by R-Pharm will support the production of Biosimilars and biologics focused on treating cancer and autoimmune diseases. In Belgium, the market is flourishing due to the presence of high quality research institutes. In addition, biopharma organizations are manufacturing and developing assets and operating on a global scale.
In Poland, the dynamic growth of the domestic biotechnological market owing to innovative research projects carried out by academic institutions and the biotech companies, as well as by the foreign investments pouring into the biotech sector, the protein sequencing market is witnessing an emerging growth. Additionally, Poland is becoming the epicenter for biotech startups and pharmaceutical companies. The Netherlands has an extraordinary reputation in medicine. Many multinational companies are investing in Holland as the country is at the forefront of biopharmaceutical research and technology.
Agilent Technologies, Inc, SGS SA, Proteome factory, Selvita, Shimadzu Corporation, etc. are some of the leading companies operating in the region.
Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with three years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments